PFE - Pfizer-Connect Biopharma deal for anti-inflammatory agent ends
2024-04-17 13:27:11 ET
Connect Biopharma ( NASDAQ: CNTB ) has decided to end a licensing deal with Pfizer ( NYSE: PFE ) for an oral anti-inflammatory agent named CBP-174 as part of its efforts to prioritize its lead asset, rademikibart....
Pfizer-Connect Biopharma deal for anti-inflammatory agent ends